Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Lung Neoplasms 8Prostatic Neoplasms 4Uterine Cervical Neoplasms 3Breast Neoplasms 3Stomach Neoplasms 2Small Cell Lung Carcinoma 2Rectal Neoplasms 2Lymphoma, Non-Hodgkin 2Lymphoma 2Hematologic Neoplasms 2Gastrointestinal Neoplasms 2Esophageal Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Anus Neoplasms 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Smoking 1Recurrence 1Pancreatic Neoplasms 1Osteosarcoma 1Oropharyngeal Neoplasms 1Nose Neoplasms 1Neuroendocrine Tumors 1Neoplasms 1Neoplasm Metastasis 1Myocarditis 1Metastatic Solid Tumors 1Melanoma 1Lymphoproliferative Disorders 1

Interventions

olaparib 1lutetium Lu 177 dotatate 1enasidenib 1Tomography, X-Ray Computed 1Radionuclide Imaging 1Positron-Emission Tomography 1Ibuprofen 1Electrocardiography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esthesioneuroblastoma, Olfactory × Tomography, X-Ray Computed × 1 year × Clear all
NCT05012098 2025-08-08

Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON).

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
11 enrolled 14 charts
CNS

Nose Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡